This inventor holds 1 USPTO granted patent. Top assignees: Children's Healthcare of Atlanta, Inc., Emory University. Active years: 2019.
Company Filing History:


Years Active: 2019
Title: The Innovative Contributions of Mario Martinez
Introduction
Mario Martinez is an accomplished inventor based in Atlanta, GA. He has made significant strides in the field of medical technology, particularly in the development of peptides that target inflamed or distressed cardiac tissue. His work has the potential to enhance diagnostic and therapeutic approaches in cardiology.
Latest Patents
Mario Martinez holds a patent for "Peptides that target inflamed or distressed cardiac tissue and uses related thereto." This patent relates to peptides that are useful for targeting inflamed or distressed tissue. In certain embodiments, the peptides comprise SEQ ID NO: 1-14, or variants or derivatives thereof. The peptides disclosed are conjugated to a label for detecting, measuring, or imaging cardiac tissue, which is useful in diagnosing myocarditis. Additionally, these peptides can be conjugated to a particle coating for applications in ultrasound imaging, MRI, or targeted therapy. Some embodiments also involve conjugating the peptides to a drug or a particle containing a drug for targeted therapy.
Career Highlights
Throughout his career, Mario Martinez has worked with notable institutions such as Emory University and Children's Healthcare of Atlanta, Inc. His contributions in these organizations have been pivotal in advancing research and development in cardiac health.
Collaborations
Mario has collaborated with various professionals in his field, including his coworker Michael K. Davis. These collaborations have fostered innovation and have led to significant advancements in medical research.
Conclusion
Mario Martinez is a prominent inventor whose work in peptide technology is paving the way for new diagnostic and therapeutic methods in cardiology. His contributions are invaluable to the medical community and hold promise for improving patient outcomes.